Computational Drug Discovery Market Competitive Analysis 2022-2028: AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro

Computational Drug Discovery Market research report Provides comprehensive information on the market offered by the key players. It offers details of market development and provides in-depth information about lucrative emerging markets, and analyzes penetration across mature market segments. The Computational Drug Discovery Market research report provides detailed information about new product launches, untapped geographies, recent developments, and investments.

Request a Free PDF Sample of the Report: https://www.reportsnreports.com/contacts/requestsample.aspx?name=6495375

Computational Drug Discovery Market research report provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players. Moreover, the Computational Drug Discovery Market Research Report primarily introduces market demands and the present position.

Descriptive company profiles of the major global players, including AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc.

Computational Drug Discovery/Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Computational Drug Discovery estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Computational Drug Discovery is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Computational Drug Discovery is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Computational Drug Discovery is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Computational Drug Discovery include AMRI, Charles River, Schrödinger, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Computational Drug Discovery companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Computational Drug Discovery market. Further, it explains the major drivers and regional dynamics of the global Computational Drug Discovery market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices.

Mentioned below are the prime players taken into account in this research report:

- AMRI
- Charles River
- Schrödinger
- Evotec
- Bayers
- GVK Biosciences
- AstraZeneca
- BioDuro
- BOC Sciences
- Aris Pharmaceuticals
- ChemDiv
- RTI International
- XRQTC
- Pharmaron

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Computational Drug Discovery Segment by Type

- Structure-based Drug Design (SBDD)
- Ligand-based Drug Design (LBDD)
- Sequence-based Approaches

Computational Drug Discovery Segment by Application

- Oncological Disorders
- Neurological Disorders
- Immunological Disorders
- Infectious Diseases
- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Computational Drug Discovery market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Computational Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Computational Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Computational Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Computational Drug Discovery revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Computational Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Computational Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.

Direct Purchase of the Research Report (FLAT 25% Discount) at: https://www.reportsnreports.com/purchase.aspx?name=6495375

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computational Drug Discovery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Structure-based Drug Design (SBDD)
1.2.3 Ligand-based Drug Design (LBDD)
1.2.4 Sequence-based Approaches
1.3 Market by Application
1.3.1 Global Computational Drug Discovery Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Oncological Disorders
1.3.3 Neurological Disorders
1.3.4 Immunological Disorders
1.3.5 Infectious Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Computational Drug Discovery Market Size (2017-2028)
2.2 Computational Drug Discovery Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Computational Drug Discovery Market Size by Region (2017-2022)
2.4 Global Computational Drug Discovery Market Size Forecast by Region (2023-2028)
2.5 Global Top Computational Drug Discovery Countries Ranking by Market Size
3 Computational Drug Discovery Competitive by Company
3.1 Global Computational Drug Discovery Revenue by Players
3.1.1 Global Computational Drug Discovery Revenue by Players (2017-2022)
3.1.2 Global Computational Drug Discovery Market Share by Players (2017-2022)
3.2 Global Computational Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Computational Drug Discovery Revenue
3.4 Global Computational Drug Discovery Market Concentration Ratio
3.4.1 Global Computational Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computational Drug Discovery Revenue in 2021
3.5 Global Computational Drug Discovery Key Players Head office and Area Served
3.6 Key Players Computational Drug Discovery Product Solution and Service
3.7 Date of Enter into Computational Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Computational Drug Discovery Breakdown Data by Type
4.1 Global Computational Drug Discovery Historic Revenue by Type (2017-2022)
4.2 Global Computational Drug Discovery Forecasted Revenue by Type (2023-2028)
5 Global Computational Drug Discovery Breakdown Data by Application
5.1 Global Computational Drug Discovery Historic Market Size by Application (2017-2022)
5.2 Global Computational Drug Discovery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Computational Drug Discovery Revenue by Company (2020-2022)
6.2 North America Computational Drug Discovery Revenue by Type (2017-2028)
6.3 North America Computational Drug Discovery Revenue by Application (2017-2028)
6.4 North America Computational Drug Discovery Revenue by Country (2017-2028)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Computational Drug Discovery Revenue by Company (2020-2022)
7.2 Europe Computational Drug Discovery Revenue by Type (2017-2028)
7.3 Europe Computational Drug Discovery Revenue by Application (2017-2028)
7.4 Europe Computational Drug Discovery Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Computational Drug Discovery Revenue by Company (2020-2022)
8.2 Asia Pacific Computational Drug Discovery Revenue by Type (2017-2028)
8.3 Asia Pacific Computational Drug Discovery Revenue by Application (2017-2028)
8.4 Asia Pacific Computational Drug Discovery Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Computational Drug Discovery Revenue by Company (2020-2022)
9.2 Latin America Computational Drug Discovery Revenue by Type (2017-2028)
9.3 Latin America Computational Drug Discovery Revenue by Application (2017-2028)
9.4 Latin America Computational Drug Discovery Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Computational Drug Discovery Revenue by Company (2020-2022)
10.2 Middle East and Africa Computational Drug Discovery Revenue by Type (2017-2028)
10.3 Middle East and Africa Computational Drug Discovery Revenue by Application (2017-2028)
10.4 Middle East and Africa Computational Drug Discovery Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.